News

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review examines their expanding role, ...
The CBS Mornings host, 70, who recently vacationed with longtime friend Oprah Winfrey, 71, and Kardashian matriarch Kris, 69, ...
Introduction: Misophonia is a recently described, poorly understood and neglected condition. It is characterized by strong negative reactions of hatred, anger or fear when subjects have to face some ...
The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and provide more health benefits.
Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same class has impressed in a recent phase 2 clinical trial – and it only ...
MariTide had a noticeable impact on weight loss. (Jastreboff et al., NEJM, 2025) Unusually, it also targets glucose-dependent insulinotropic polypeptide (GIP) receptors, which are also involved in ...
“The data demonstrates the potential for once monthly or less frequent dosing and are particularly encouraging as we seek sustainable, long-term treatments for people living with obesity, with and ...
"Once-monthly treatment options for type 2 diabetes have long been sought after, yet elusive," said Ania M. Jastreboff, MD, PhD, professor at Yale School of Medicine (Endocrinology), director of ...